AGP Executive Report
Last update: 10 hours agoAlcohol-Linked Cancer: A new U.S. study finds alcohol-attributable cancer deaths doubled from 1990 to 2023, with rising burdens across ages and cancers beyond the liver, including colorectal and breast. Public Health Trust: A national survey shows Americans’ confidence in their own clinicians stays high, while trust in CDC, FDA, and NIH has fallen sharply since 2024. Prescription Drug Sticker Shock: A White House push on drug pricing is criticized as falling short, with critics noting the exact terms of new deals remain unclear and costs may still rise. Medicaid Pressure on Hospitals: Texas hospitals say they’re losing $27 million a day as federal Medicaid reimbursements are withheld, raising fears of service cuts for low-income patients. State Disease Alerts: Florida reports 22 leprosy (Hansen’s disease) cases in 2026, keeping it among the top hotspots. Behavioral Health Progress: Louisiana reports major opioid-related death and emergency visit declines from 2022 to 2025, alongside broader survey data on treatment access. Care Access & Housing: A Fond du Lac shelter gets a $50,000 gift to keep a warming shelter running for medically vulnerable people discharged from hospitals. Clinical Research Expansion: Ark Clinical Research joins Genentech’s inclusive trial site alliance to broaden patient participation.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.